Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study

(2019) Koichi Mitsuya et al.   PLoS One

Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases

(2019) Daniel N. Cagney et al.   JAMA Oncology

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

(2019) Zeynep Eroglu et al.   Pigment Cell & Melanoma Research

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

(2019) Adrienne Boire et al.   NEURO-ONCOLOGY

Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid

(2019) Alexandra M. Miller et al.   NATURE

Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)

(2019) Sherise D. Ferguson et al.   JOURNAL OF NEURO-ONCOLOGY

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

(2018) Y S Li et al.   ANNALS OF ONCOLOGY

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease

(2018) Leomar Y Ballester et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse After Haploidentical Hematopoietic Stem Cell Transplantation

(2018) Azusa Mayumi et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

(2018) Georgina V Long et al.   LANCET ONCOLOGY

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors

(2018) Brian V Nahed et al.   NEUROSURGERY

Operative Complications with and without Image Guidance: A Systematic Review and Meta-Analysis of the Ommaya Reservoir Literature

(2018) Jonathan C. Lau et al.   World Neurosurgery

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases

(2017) Noelle L. Williams et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient

(2017) Isabella C. Glitza et al.   JOURNAL OF NEURO-ONCOLOGY

Dabrafenib plus trametinib in patients with BRAF V600 -mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

(2017) Michael A Davies et al.   LANCET ONCOLOGY

Integrating liquid biopsies into the management of cancer

(2017) Giulia Siravegna et al.   Nature Reviews Clinical Oncology

Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors

(2017) Xuling Lin et al.   NEURO-ONCOLOGY

Leptomeningeal melanoma-A case series in the era of modern systemic therapy

(2017) Malmaruha Arasaratnam et al.   Pigment Cell & Melanoma Research

Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma

(2016) M. H. Geukes Foppen et al.   ANNALS OF ONCOLOGY

Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy

(2016) Keiran S.M. Smalley et al.   INTERNATIONAL JOURNAL OF CANCER

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

(2016) Elena I. Pentsova et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases

(2016) Yingmei Li et al.   JOURNAL OF NEURO-ONCOLOGY

Vemurafenib in leptomeningeal carcinomatosis from melanoma

(2016) Charalampos S. Floudas et al.   MELANOMA RESEARCH

Melanoma central nervous system metastases: current approaches, challenges, and opportunities

(2016) Justine V. Cohen et al.   Pigment Cell & Melanoma Research

T-Lymphocytes Traffic into the Brain across the Blood-CSF Barrier: Evidence Using a Reconstituted Choroid Plexus Epithelium

(2016) Nathalie Strazielle et al.   PLoS One

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies

(2016) Parisa Momtaz et al.   Oncotarget

Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy

(2015) K. A. Ahmed et al.   ANNALS OF ONCOLOGY

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report

(2015) Dae Won Kim et al.   BMC CANCER

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial

(2015) Renata Ursu et al.   CANCER SCIENCE

Complete Cytologic Remission of V600E BRAF-Mutant Melanoma–Associated Leptomeningeal Carcinomatosis Upon Treatment With Dabrafenib

(2015) Sofie Wilgenhof et al.   JOURNAL OF CLINICAL ONCOLOGY

Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma

(2015) Lilia Sakji-Dupré et al.   MELANOMA RESEARCH

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

(2015) Christina Twyman-Saint Victor et al.   NATURE

IMCT-07THERAPEUTIC OUTCOMES OF INTRATHECAL INTERLEUKIN-2 IN METASTATIC MELANOMA PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD)

(2015) Isabella C. Glitza et al.   NEURO-ONCOLOGY

Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases

(2015) Heike Seifert et al.   Pigment Cell & Melanoma Research

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

(2015) Leticia De Mattos-Arruda et al.   Nature Communications

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report

(2015) I. C. Glitza et al.   Cancer Immunology Research

Beyond BRAF: where next for melanoma therapy?

(2014) I V Fedorenko et al.   BRITISH JOURNAL OF CANCER

Immune cell trafficking from the brain maintains CNS immune tolerance

(2014) Mohammad G. Mohammad et al.   JOURNAL OF CLINICAL INVESTIGATION

Intrathecal Interleukin-2 for Melanomatous Meningitis

(2014) Nicole A. Shonka et al.   JOURNAL OF CLINICAL ONCOLOGY

Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

(2014) Vinai Gondi et al.   JOURNAL OF CLINICAL ONCOLOGY

Gamma Knife radiosurgery to four or more brain metastases in patients without prior intracranial radiation or surgery

(2014) Eric Ojerholm et al.   Cancer Medicine

Vemurafenib for Leptomeningeal Melanomatosis

(2013) Niklas Schäfer et al.   JOURNAL OF CLINICAL ONCOLOGY

Ommaya reservoir-related infections: Clinical manifestations and treatment outcomes

(2013) Ariel D. Szvalb et al.   JOURNAL OF INFECTION

Ommaya reservoir infections: A 16-year retrospective analysis

(2013) Peter A. Mead et al.   JOURNAL OF INFECTION

Detection and quantification of CSF malignant cells by the CellSearch® technology in patients with melanoma leptomeningeal metastasis

(2013) Emilie Le Rhun et al.   MEDICAL ONCOLOGY

Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib

(2013) Jee Min Lee et al.   MELANOMA RESEARCH

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

(2013) P. D. Brown et al.   NEURO-ONCOLOGY

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

(2012) Heike Niessner et al.   Cancer Medicine

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

(2011) S. A. Rosenberg et al.   CLINICAL CANCER RESEARCH

Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study

(2011) Ning Lin et al.   JOURNAL OF NEUROSURGERY

Prognostic factors for survival in melanoma patients with brain metastases

(2010) Michael A. Davies et al.   CANCER

Intrathecal gene therapy for treatment of leptomeningeal carcinomatosis

(2010) John D. Heiss et al.   JOURNAL OF NEURO-ONCOLOGY

Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma

(2008) Michael B. Atkins et al.   CANCER